MENU
+Compare
ZTS
Stock ticker: NYSE
AS OF
Jan 14 closing price
Price
$125.84
Change
+$1.22 (+0.98%)
Capitalization
55.46B

ZTS ZOETIS Forecast, Technical & Fundamental Analysis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ZTS with price predictions
Jan 13, 2026

ZTS in upward trend: price rose above 50-day moving average on January 05, 2026

ZTS moved above its 50-day moving average on January 05, 2026 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for ZTS crossed bullishly above the 50-day moving average on January 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 267 cases where ZTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ZTS moved out of overbought territory on January 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZTS as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZTS broke above its upper Bollinger Band on January 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.277) is normal, around the industry mean (29.656). P/E Ratio (21.185) is within average values for comparable stocks, (75.571). Projected Growth (PEG Ratio) (2.362) is also within normal values, averaging (2.019). Dividend Yield (0.016) settles around the average of (0.030) among similar stocks. P/S Ratio (5.984) is also within normal values, averaging (72.365).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ZTS is expected to report earnings to fall 17.65% to $1.40 per share on February 12

ZOETIS ZTS Stock Earnings Reports
Q4'25
Est.
$1.40
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.02
The last earnings report on November 04 showed earnings per share of $1.70, beating the estimate of $1.62. With 3.36M shares outstanding, the current market capitalization sits at 55.46B.
A.I.Advisor
published Dividends

ZTS is expected to pay dividends on March 03, 2026

ZOETIS ZTS Stock Dividends
A dividend of $0.53 per share will be paid with a record date of March 03, 2026, and an ex-dividend date of January 20, 2026. The last dividend of $0.50 was paid on December 02. Read more...
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DTRE39.940.14
+0.34%
First Trust Alerian Dsrupt Tech RE ETF
CPSD26.110.01
+0.06%
Calamos S&P 500 Str Alt Prt ETF-Dec
JMUB50.750.01
+0.01%
JPMorgan Municipal ETF
LEGR61.36-0.21
-0.34%
First Trust Indxx Invtv Tnsctn&Prcs ETF
ISCF42.78-0.31
-0.72%
iShares MSCI Intl Small-Cap Mltfct ETF

ZTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.56%
ELAN - ZTS
47%
Loosely correlated
+2.43%
PAHC - ZTS
38%
Loosely correlated
+1.58%
VTRS - ZTS
38%
Loosely correlated
+5.44%
PRGO - ZTS
36%
Loosely correlated
+0.80%
AMPH - ZTS
36%
Loosely correlated
-1.67%
More

Groups containing ZTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.56%
Pharmaceuticals: Generic
industry (218 stocks)
39%
Loosely correlated
+0.27%